Prevalence and management of non-albicans vaginal candidiasis

Sexually Transmitted Infections

Volumn 86, Issue 2, 2010, Pages 99-100

  Hetticarachchi, Nalin ^a   Ashbee, H Ruth ^a   Wilson, Janet D ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; FLUCYTOSINE;

ARTICLE; DRUG EFFICACY; FOLLOW UP; FUNGUS CULTURE; FUNGUS ISOLATION; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME; VAGINA CANDIDIASIS;

ADMINISTRATION, INTRAVAGINAL; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; DRUG THERAPY, COMBINATION; FEMALE; FLUCYTOSINE; HUMANS; OINTMENTS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 77950157789     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2009.040386     Document Type: Article

References (6)

1. Holland J, Young ML, Lee O, et al. Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect 2003;79:249-50.
2. Walker PP, Reynolds MT, Ashbee HR, et al. Vaginal yeasts in the era of 'over the counter' antifungals. Sex Transm Infect 2000;76:437-8.
3. Fidel PL, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis and clinical disease with comparison to C albicans. Clin Microbiol Rev 1999;12:80-96.
4. National guideline on the management of vulvovaginal candidiasis. Clinical Effectiveness Group, British Association of Sexual Health and HIV, 2007. http://www. bashh.org/guidelines.
5. White DJ, Habib AR, Vanthuyne A, et al. Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections. Sex Transm Infect 2001;77:212-3.
6. Shann S, Wilson J. Treatment of Candida glabrata using topical amphotericin B and flucytosine. Sex Transm Infect 2003;79:265-6.